Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report

被引:4
|
作者
Sugioka, Koji [1 ]
Kodama, Aya [1 ]
Yoshida, Koji [2 ]
Okada, Kiyotaka [3 ]
Fukuda, Masahiko [1 ]
Shimomura, Yoshikazu [1 ]
机构
[1] Kinki Univ, Fac Med, Dept Ophthalmol, Osakasayama 5898511, Japan
[2] Kinki Univ, Fac Med, Dept Biochem, Osakasayama 5898511, Japan
[3] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama 5898511, Japan
来源
BMC OPHTHALMOLOGY | 2012年 / 12卷
关键词
u-PA; u-PAR; Corneal wound healing; alpha; 2-antiplasmin; Corneal perforation; MATRIX METALLOPROTEINASES; UPAR; GROWTH-FACTOR-BETA-1; DIFFERENTIATION; CONTRACTION; KERATOCYTE; INHIBITORS;
D O I
10.1186/1471-2415-12-60
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Corneal ulceration leading to perforation is associated with infectious and non-infectious destructive conditions in the cornea. The fibrinolytic (plasminogen/plasmin) system is considered to contribute to tissue remodeling in the wound healing process and it is believed to play an important role in proteolysis and fibrosis. To determine the localization of urokinase-type plasminogen activator (u-PA), u-PA receptor (u-PAR) and alpha 2-antiplasmin (alpha 2AP) in the tissue of a corneal perforation, we investigated immunohistochemical expressions of u-PA, u-PAR, alpha 2AP, CD68, and alpha-smooth muscle actin (alpha-SMA) in a patient with corneal perforation that developed from an ulcer of no clear cause. Case presentation: The patient was a 77-year-old woman who presented with a perforated corneal ulcer in her right eye. The cause of her corneal ulcer was unknown. Double immunohistochemistry was performed for the combinations of u-PA with u-PAR, CD68 or alpha-SMA and alpha 2AP with CD68 or alpha-SMA to detect the localization of u-PA and alpha 2AP. u-PA and u-PAR co-localization was seen in the corneal ulceration area. u-PA was mainly observed in CD68-positive cells and in some alpha-SMA positive cells. On the other hand, alpha 2AP was not expressed in CD68-positive cells, but was expressed in alpha-SMA positive cells. Conclusion: We identified expression of the u-PA/u-PAR complex and alpha 2AP in a patient with a corneal ulcer. These two molecules are believed to play a crucial role in inflammatory cell recruitment, ECM synthesis and degradation during corneal wound healing.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
    Koji Sugioka
    Aya Kodama
    Koji Yoshida
    Kiyotaka Okada
    Masahiko Fukuda
    Yoshikazu Shimomura
    BMC Ophthalmology, 12
  • [2] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [3] Urokinase-type plasminogen activator
    Crippa, Massimo P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (04): : 690 - 694
  • [4] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [5] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [6] Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator
    Jo, MJ
    Thomas, KS
    Marozkina, N
    Amin, TJ
    Silva, CM
    Parsons, SJ
    Gonias, SL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17449 - 17457
  • [7] Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas
    Christensen, L
    Simonsen, ACW
    Heegaard, CW
    Moestrup, SK
    Andersen, JA
    Andreasen, PA
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (04) : 441 - 452
  • [8] Urokinase-type plasminogen activator receptor: A beacon of malignancy?
    Drapkin, Ronny
    Clauss, Adam
    Skates, Steven
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5643 - 5645
  • [9] Urokinase-type plasminogen activator receptor in IgA nephropathy
    Ahn, Shin-Young
    Chin, Ho Jun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 166 - 169
  • [10] A CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BELIN, D
    BACCINO, D
    WOHLWEND, A
    ESTREICHER, A
    HUARTE, J
    VASSALLI, JD
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 46 - 46